##gff-version 3
P40380	UniProtKB	Chain	1	230	.	.	.	ID=PRO_0000097531;Note=Cyclin-dependent kinase inhibitor rum1	
P40380	UniProtKB	Region	1	25	.	.	.	Note=Disordered;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite	
P40380	UniProtKB	Region	43	118	.	.	.	Note=Disordered;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite	
P40380	UniProtKB	Region	67	147	.	.	.	Note=CDK inhibitory and cyclin-binding	
P40380	UniProtKB	Region	101	230	.	.	.	Note=Required for activity as a cdc2 kinase inhibitor	
P40380	UniProtKB	Region	187	230	.	.	.	Note=Disordered;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite	
P40380	UniProtKB	Compositional bias	79	93	.	.	.	Note=Basic and acidic residues;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite	
P40380	UniProtKB	Modified residue	13	13	.	.	.	Note=Phosphothreonine%3B by MAPK;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12135491;Dbxref=PMID:12135491	
P40380	UniProtKB	Modified residue	19	19	.	.	.	Note=Phosphoserine%3B by MAPK;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12135491;Dbxref=PMID:12135491	
P40380	UniProtKB	Modified residue	58	58	.	.	.	Note=Phosphothreonine%3B by cdc2;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9430640;Dbxref=PMID:9430640	
P40380	UniProtKB	Modified residue	62	62	.	.	.	Note=Phosphothreonine%3B by cdc2;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9430640;Dbxref=PMID:9430640	
P40380	UniProtKB	Mutagenesis	5	5	.	.	.	Note=No effect on phenotype and no reduction in 32-P incorporation mediated by MAPK. T->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12135491,ECO:0000269|PubMed:9430640;Dbxref=PMID:12135491,PMID:9430640	
P40380	UniProtKB	Mutagenesis	13	13	.	.	.	Note=No effect on phenotype%3B when associated with A-16 and A-19. Reduced 32-P incorporation mediated by MAPK%3B when associated with A-19. T->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12135491,ECO:0000269|PubMed:9430640;Dbxref=PMID:12135491,PMID:9430640	
P40380	UniProtKB	Mutagenesis	13	13	.	.	.	Note=Reduces activity as a cdc2 inhibitor%3B when associated with E-19. T->E;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12135491,ECO:0000269|PubMed:9430640;Dbxref=PMID:12135491,PMID:9430640	
P40380	UniProtKB	Mutagenesis	16	16	.	.	.	Note=No effect on phenotype%3B when associated with A-13 and A-19. No reduction in 32-P incorporation mediated by MAPK. T->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12135491,ECO:0000269|PubMed:9430640;Dbxref=PMID:12135491,PMID:9430640	
P40380	UniProtKB	Mutagenesis	19	19	.	.	.	Note=No effect on phenotype%3B when associated with A-13 and A-16. Reduced 32-P incorporation mediated by MAPK%3B when associated with A-13. S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12135491,ECO:0000269|PubMed:9430640;Dbxref=PMID:12135491,PMID:9430640	
P40380	UniProtKB	Mutagenesis	19	19	.	.	.	Note=Reduces activity as a cdc2 inhibitor%3B when associated with E-13. S->E;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12135491,ECO:0000269|PubMed:9430640;Dbxref=PMID:12135491,PMID:9430640	
P40380	UniProtKB	Mutagenesis	58	58	.	.	.	Note=Reduces growth rate into small colonies containing many elongated cells. Phenotype enhances due to increased stability%3B when associated with A-62. No reduction in 32-P incorporation mediated by MAPK. T->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12135491,ECO:0000269|PubMed:9430640;Dbxref=PMID:12135491,PMID:9430640	
P40380	UniProtKB	Mutagenesis	58	58	.	.	.	Note=Shift in mobility%3B when associated with S-62. T->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12135491,ECO:0000269|PubMed:9430640;Dbxref=PMID:12135491,PMID:9430640	
P40380	UniProtKB	Mutagenesis	62	62	.	.	.	Note=Reduces growth rate into small colonies containing many elongated cells. Phenotype enhances due to increased stability%3B when associated with A-58. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9430640;Dbxref=PMID:9430640	
P40380	UniProtKB	Mutagenesis	62	62	.	.	.	Note=Shift in mobility%3B when associated with S-58. T->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9430640;Dbxref=PMID:9430640	
P40380	UniProtKB	Mutagenesis	110	110	.	.	.	Note=No effect on phenotype. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9430640;Dbxref=PMID:9430640	
P40380	UniProtKB	Mutagenesis	212	212	.	.	.	Note=No effect on phenotype. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9430640;Dbxref=PMID:9430640	
P40380	UniProtKB	Sequence conflict	72	73	.	.	.	Note=ML->IV;Ontology_term=ECO:0000305;evidence=ECO:0000305